kanamycin a has been researched along with digoxin in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Carruthers, MM; Kanokvechayant, R | 1 |
| Christiansen, NJ; Hansen, JM; Kampmann, JP; Kristensen, M; Køolendorf, K; Lumholtz, B; Siersbaek-Nielsen, K | 1 |
| Mokgokong, ET | 1 |
| Kauffman, SL; Lynfield, J; Webber, CB; Yao, AC | 1 |
1 review(s) available for kanamycin a and digoxin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for kanamycin a and digoxin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Pseudomonas aeruginosa endocarditis. Report of a case, with review of the literature.
Topics: Adult; Age Factors; Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Diabetes Complications; Digoxin; Drug Hypersensitivity; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Heart Failure; Humans; Kanamycin; Male; Neurologic Manifestations; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Sex Factors; Substance-Related Disorders | 1973 |
[Dosage regime for kanamycin, gentamicin and digoxin. Presentation of a slide-rule for the calculation of creatinine clearance and doses of drugs].
Topics: Adolescent; Adult; Aged; Creatinine; Digoxin; Female; Gentamicins; Humans; Kanamycin; Male; Middle Aged | 1974 |
Treatment of septicaemic shock in gynaecology and obstetrics.
Topics: Abortion, Septic; Adrenal Cortex Hormones; Bicarbonates; Blood Transfusion; Chloramphenicol; Digoxin; Escherichia coli Infections; Exchange Transfusion, Whole Blood; Female; Gentamicins; Humans; Hysterectomy; Isoproterenol; Kanamycin; Penicillins; Plasma Substitutes; Pregnancy; Puerperal Infection; Sepsis; Shock, Septic; Tetracycline | 1973 |
Origin of the right pulmonary artery from the aorta. A clinical-pathologic study of two types based on caliber of the pulmonary artery.
Topics: Digoxin; Electrocardiography; Humans; Infant; Kanamycin; Lung; Male; Organomercury Compounds; Penicillins; Pulmonary Artery; Radiography; Vascular Diseases | 1967 |